Risk factor
Negligible price volatility
Profitability factor
Excellent dividends
In Guru Portfolios
Manager | Fund | Portfolio Weight (%) | Change |
|---|---|---|---|
| Michael Burry | Scion Asset Management | 11.1% | +11.07% |
| Steven Cohen | Point72 Asset Management, L.P. | 0.1% | -0.14% |
| Kenneth Griffin | CITADEL ADVISORS LLC | 0.1% | -0.03% |
About
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT
Target Price
The average target price of PFE is 29.9 and suggests 3.11% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation